Shield Therapeutics plc (AIM: STX)
Health Care · Pharmaceuticals · GB
£0.05
-11.76% today · -30.8% 1Y
Shield Therapeutics plc (AIM: STX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $84.22M.
Over the last twelve months the share price has lost 30.8%, trading between 0.04 and 0.13.
Tweenvest scores Shield Therapeutics plc across four factors: quality 28/100, value 65/100, growth 100/100. Its strongest factor is growth.
STX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $84.22M
- Revenue (TTM)
- $58.63M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.73
- 52-week high
- £0.13
- 52-week low
- £0.04
- Avg volume (3M)
- —
- Shares outstanding
- 1.07B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lee's Pharmaceutical Holdings LimitedSEHK: 950 | $87.80M | HK$1.17 | -1.27% |
| Fusen Pharmaceutical Company LimitedSEHK: 1652 | $87.15M | HK$0.93 | +15.63% |
| Dar Al Dawa Development and Investment Co. Ltd.ASE: DADI | $86.79M | JD1.23 | +1.65% |
| Jeil Pharma Holdings IncKOSE: A002620 | $84.92M | ₩7,450.00 | -0.67% |
| Vistin Pharma ASAOB: VISTN | $83.84M | Nkr18.10 | -0.55% |
| Zhongzhi Pharmaceutical Holdings LimitedSEHK: 3737 | $83.09M | HK$0.76 | +4.86% |
| Ahn-Gook Pharmaceutical Co., Ltd.KOSDAQ: A001540 | $82.79M | ₩9,810.00 | -1.90% |
| HLS Therapeutics Inc.TSX: HLS | $82.64M | CA$4.20 | +8.53% |
Figures last refreshed Oct 4, 2026.